Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Connors

Showing results (651-660 of 977) with videos related to

Pageof 98
Sort By:
European Journal of Internal Medicine|February 11, 2023
Risk factors for recurrence and major bleeding in patients with cancer-associated venous thromboembolismMaria Cristina Vedovati, Michela Giustozzi, Andrés Munoz, et al.
Journal of Thrombosis and Thrombolysis|December 21, 2017
The use of prophylactic anticoagulation during induction and consolidation chemotherapy in adults with acute lymphoblastic leukemiaRachael F Grace, Daniel J DeAngelo, Kristen E Stevenson, et al.
Blood|April 10, 2014
Advanced-stage nodular lymphocyte predominant Hodgkin lymphoma compared with classical Hodgkin lymphoma: a matched pair outcome analysisKatharine H Xing, Joseph M Connors, Anky Lai, et al.
Leukemia & Lymphoma|April 22, 2023
Population-level impact of ibrutinib for chronic lymphocytic leukemia in British Columbia, CanadaRania S Khelifi, Steven J Huang, Kerry J Savage, et al.
Thrombosis and Haemostasis|January 10, 2024
Early Time Courses of Recurrent Venous Thromboembolism and Bleeding during Apixaban or Dalteparin Therapy for Patients with CancerAlexander T Cohen, Katherine J Creeper, Raza Alikhan, et al.
Thrombosis and Haemostasis|September 16, 2021
Apixaban and Dalteparin for the Treatment of Venous Thromboembolism in Patients with Different Sites of CancerGiancarlo Agnelli, Andrés Muñoz, Laura Franco, et al.
British Journal of Haematology|December 17, 2016
Brentuximab vedotin and bendamustine produce high complete response rates in patients with chemotherapy refractory Hodgkin lymphomaMatko Kalac, Jennifer K Lue, Emily Lichtenstein, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 1, 2000
HLA B*5701 is highly associated with restriction of virus replication in a subgroup of HIV-infected long term nonprogressorsS A Migueles, M S Sabbaghian, W L Shupert, et al.
Blood|November 26, 2008
Diffuse large B-cell lymphoma: reduced CD20 expression is associated with an inferior survivalNathalie A Johnson, Merrill Boyle, Ali Bashashati, et al.
Global Change Biology|October 8, 2024
Body size and early marine conditions drive changes in Chinook salmon productivity across northern latitude ecosystemsMegan L Feddern, Rebecca Shaftel, Erik R Schoen, et al.
Pageof 98

Showing results (651-660 of 977) with videos related to

Sort By:
Pageof 98
European Journal of Internal Medicine|February 11, 2023
Risk factors for recurrence and major bleeding in patients with cancer-associated venous thromboembolismMaria Cristina Vedovati, Michela Giustozzi, Andrés Munoz, et al.
Journal of Thrombosis and Thrombolysis|December 21, 2017
The use of prophylactic anticoagulation during induction and consolidation chemotherapy in adults with acute lymphoblastic leukemiaRachael F Grace, Daniel J DeAngelo, Kristen E Stevenson, et al.
Blood|April 10, 2014
Advanced-stage nodular lymphocyte predominant Hodgkin lymphoma compared with classical Hodgkin lymphoma: a matched pair outcome analysisKatharine H Xing, Joseph M Connors, Anky Lai, et al.
Leukemia & Lymphoma|April 22, 2023
Population-level impact of ibrutinib for chronic lymphocytic leukemia in British Columbia, CanadaRania S Khelifi, Steven J Huang, Kerry J Savage, et al.
Thrombosis and Haemostasis|January 10, 2024
Early Time Courses of Recurrent Venous Thromboembolism and Bleeding during Apixaban or Dalteparin Therapy for Patients with CancerAlexander T Cohen, Katherine J Creeper, Raza Alikhan, et al.
Thrombosis and Haemostasis|September 16, 2021
Apixaban and Dalteparin for the Treatment of Venous Thromboembolism in Patients with Different Sites of CancerGiancarlo Agnelli, Andrés Muñoz, Laura Franco, et al.
British Journal of Haematology|December 17, 2016
Brentuximab vedotin and bendamustine produce high complete response rates in patients with chemotherapy refractory Hodgkin lymphomaMatko Kalac, Jennifer K Lue, Emily Lichtenstein, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 1, 2000
HLA B*5701 is highly associated with restriction of virus replication in a subgroup of HIV-infected long term nonprogressorsS A Migueles, M S Sabbaghian, W L Shupert, et al.
Blood|November 26, 2008
Diffuse large B-cell lymphoma: reduced CD20 expression is associated with an inferior survivalNathalie A Johnson, Merrill Boyle, Ali Bashashati, et al.
Global Change Biology|October 8, 2024
Body size and early marine conditions drive changes in Chinook salmon productivity across northern latitude ecosystemsMegan L Feddern, Rebecca Shaftel, Erik R Schoen, et al.
Pageof 98